
On Tuesday, EU industry chief Thierry Breton announced that the European Union has approved a 43-billion-euro plan to enhance its semiconductor industry in an attempt to compete with the United States and Asia.
Negotiations on the Chips Act between the European Commission, EU countries, and EU lawmakers took place in Strasbourg to finalize the details.
“We reached a deal on the EU Chips Act,” Breton told a news conference.
The Chips Act has a goal of increasing the bloc’s global chip output to 20% by 2030. This follows the United States’ announcement of the CHIPS for America Act, which is aimed at competing with Chinese technology.
Read more: EU Chips Act To Be Approved In One Week
The scope of funding for chip production in the EU has been expanded by governments and lawmakers to include the entire value chain, encompassing older chips and research and design facilities, despite the Commission’s initial proposal to fund only cutting-edge chip plants.
US chipmaker Intel, which will get German subsidies for a plant in Germany, welcomed the deal.
“The EU Chips Act will crowd-in investments to where they are most needed – in manufacturing capabilities, skills, and R&D. The strong and broad political support for these objectives shows that the EU is serious about securing its future prosperity,” Hendrik Bourgeois, VP European Government Affairs at Intel, said.
Featured News
Judge Orders Apple to Address Fortnite App Block or Face Court Hearing
May 19, 2025 by
CPI
EU Civil Society Groups and Labor Unions Raise Alarm Over Proposed Changes to GDPR
May 19, 2025 by
CPI
EU Antitrust Regulators Push Back Deadline on UniCredit’s Takeover Bid for Banco BPM
May 19, 2025 by
CPI
Intel Challenges €376 Million EU Fine in Ongoing Antitrust Dispute
May 19, 2025 by
CPI
Red Bull Challenges EU Commission Over Lengthy Antitrust Inspection
May 19, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas